Distribution pattern following systemic mesenchymal stem cell injection depends on the age of the recipient and neuronal health

BACKGROUND: Mesenchymal stem cells (MSCs) show therapeutic efficacy in many different age-related degenerative diseases, including Alzheimer's disease. Very little is currently known about whether or not aging impacts the transplantation efficiency of MSCs. METHODS: In this study, we investigat...

Full description

Saved in:
Bibliographic Details
Main Authors: Claire Fabian, Yahaira Naaldijk, Christiane Leovsky, Adiv A. Johnson, Lukas Rudolph, Carsten Jaeger, Katrin Arnold, Alexandra Stolzing
Format: Default Article
Published: 2017
Subjects:
Online Access:https://hdl.handle.net/2134/24850
Tags: Add Tag
No Tags, Be the first to tag this record!
id rr-article-9573596
record_format Figshare
spelling rr-article-95735962017-01-01T00:00:00Z Distribution pattern following systemic mesenchymal stem cell injection depends on the age of the recipient and neuronal health Claire Fabian (3933104) Yahaira Naaldijk (3933095) Christiane Leovsky (3933107) Adiv A. Johnson (7204571) Lukas Rudolph (3933101) Carsten Jaeger (667379) Katrin Arnold (3933092) Alexandra Stolzing (1251348) Mechanical engineering not elsewhere classified Aging Alzheimer’s disease Biodistribution Mesenchymal stem cells Systemic injection Mechanical Engineering not elsewhere classified BACKGROUND: Mesenchymal stem cells (MSCs) show therapeutic efficacy in many different age-related degenerative diseases, including Alzheimer's disease. Very little is currently known about whether or not aging impacts the transplantation efficiency of MSCs. METHODS: In this study, we investigated the distribution of intravenously transplanted syngeneic MSCs derived from young and aged mice into young, aged, and transgenic APP/PS1 Alzheimer's disease mice. MSCs from male donors were transplanted into female mice and their distribution pattern was monitored by PCR using Y-chromosome specific probes. Biodistribution of transplanted MSCs in the brains of APP/PS1 mice was additionally confirmed by immunofluorescence and confocal microscopy. RESULTS: Four weeks after transplantation into young mice, young MSCs were found in the lung, axillary lymph nodes, blood, kidney, bone marrow, spleen, liver, heart, and brain cortex. In contrast, young MSCs that were transplanted into aged mice were only found in the brain cortex. In both young and aged mouse recipients, transplantation of aged MSCs showed biodistribution only in the blood and spleen. Although young transplanted MSCs only showed neuronal distribution in the brain cortex in young mice, they exhibited a wide neuronal distribution pattern in the brains of APP/PS1 mice and were found in the cortex, cerebellum, hippocampus, olfactory bulb, and brainstem. The immunofluorescent signal of both transplanted MSCs and resident microglia was robust in the brains of APP/PS1 mice. Monocyte chemoattractant-1 levels were lowest in the brain cortex of young mice and were significantly increased in APP/PS1 mice. Within the hippocampus, monocyte chemoattractant-1 levels were significantly higher in aged mice compared with younger and APP/PS1 mice. CONCLUSIONS: We demonstrate in vivo that MSC biodistribution post transplantation is detrimentally affected by aging and neuronal health. Aging of both the recipient and the donor MSCs used attenuates transplantation efficiency. Clinically, our data would suggest that aged MSCs should not be used for transplantation and that transplantation of MSCs into aged patients will be less efficacious. 2017-01-01T00:00:00Z Text Journal contribution 2134/24850 https://figshare.com/articles/journal_contribution/Distribution_pattern_following_systemic_mesenchymal_stem_cell_injection_depends_on_the_age_of_the_recipient_and_neuronal_health/9573596 CC BY 4.0
institution Loughborough University
collection Figshare
topic Mechanical engineering not elsewhere classified
Aging
Alzheimer’s disease
Biodistribution
Mesenchymal stem cells
Systemic injection
Mechanical Engineering not elsewhere classified
spellingShingle Mechanical engineering not elsewhere classified
Aging
Alzheimer’s disease
Biodistribution
Mesenchymal stem cells
Systemic injection
Mechanical Engineering not elsewhere classified
Claire Fabian
Yahaira Naaldijk
Christiane Leovsky
Adiv A. Johnson
Lukas Rudolph
Carsten Jaeger
Katrin Arnold
Alexandra Stolzing
Distribution pattern following systemic mesenchymal stem cell injection depends on the age of the recipient and neuronal health
description BACKGROUND: Mesenchymal stem cells (MSCs) show therapeutic efficacy in many different age-related degenerative diseases, including Alzheimer's disease. Very little is currently known about whether or not aging impacts the transplantation efficiency of MSCs. METHODS: In this study, we investigated the distribution of intravenously transplanted syngeneic MSCs derived from young and aged mice into young, aged, and transgenic APP/PS1 Alzheimer's disease mice. MSCs from male donors were transplanted into female mice and their distribution pattern was monitored by PCR using Y-chromosome specific probes. Biodistribution of transplanted MSCs in the brains of APP/PS1 mice was additionally confirmed by immunofluorescence and confocal microscopy. RESULTS: Four weeks after transplantation into young mice, young MSCs were found in the lung, axillary lymph nodes, blood, kidney, bone marrow, spleen, liver, heart, and brain cortex. In contrast, young MSCs that were transplanted into aged mice were only found in the brain cortex. In both young and aged mouse recipients, transplantation of aged MSCs showed biodistribution only in the blood and spleen. Although young transplanted MSCs only showed neuronal distribution in the brain cortex in young mice, they exhibited a wide neuronal distribution pattern in the brains of APP/PS1 mice and were found in the cortex, cerebellum, hippocampus, olfactory bulb, and brainstem. The immunofluorescent signal of both transplanted MSCs and resident microglia was robust in the brains of APP/PS1 mice. Monocyte chemoattractant-1 levels were lowest in the brain cortex of young mice and were significantly increased in APP/PS1 mice. Within the hippocampus, monocyte chemoattractant-1 levels were significantly higher in aged mice compared with younger and APP/PS1 mice. CONCLUSIONS: We demonstrate in vivo that MSC biodistribution post transplantation is detrimentally affected by aging and neuronal health. Aging of both the recipient and the donor MSCs used attenuates transplantation efficiency. Clinically, our data would suggest that aged MSCs should not be used for transplantation and that transplantation of MSCs into aged patients will be less efficacious.
format Default
Article
author Claire Fabian
Yahaira Naaldijk
Christiane Leovsky
Adiv A. Johnson
Lukas Rudolph
Carsten Jaeger
Katrin Arnold
Alexandra Stolzing
author_facet Claire Fabian
Yahaira Naaldijk
Christiane Leovsky
Adiv A. Johnson
Lukas Rudolph
Carsten Jaeger
Katrin Arnold
Alexandra Stolzing
author_sort Claire Fabian (3933104)
title Distribution pattern following systemic mesenchymal stem cell injection depends on the age of the recipient and neuronal health
title_short Distribution pattern following systemic mesenchymal stem cell injection depends on the age of the recipient and neuronal health
title_full Distribution pattern following systemic mesenchymal stem cell injection depends on the age of the recipient and neuronal health
title_fullStr Distribution pattern following systemic mesenchymal stem cell injection depends on the age of the recipient and neuronal health
title_full_unstemmed Distribution pattern following systemic mesenchymal stem cell injection depends on the age of the recipient and neuronal health
title_sort distribution pattern following systemic mesenchymal stem cell injection depends on the age of the recipient and neuronal health
publishDate 2017
url https://hdl.handle.net/2134/24850
_version_ 1797464993286848512